Literature DB >> 28194798

Colorectal cancer-global burden, trends, and geographical variations.

Jeffrey Douaiher1, Advaitaa Ravipati2, Benjamin Grams1, Sanjib Chowdhury3, Olusegun Alatise4, Chandrakanth Are1.   

Abstract

BACKGROUND: The aim of this study is to describe the trends and variations in the global burden of colorectal cancer (CRC).
METHODS: Data (2012-2030) relating to CRC was extracted from GLOBOCAN 2012 database and analyzed.
RESULTS: The results of our study demonstrate a rising global burden of colorectal cancer which persists until the year 2035 and likely beyond. The rise in the global burden is not uniform with significant variations influenced by geographic location, socio-economic status, age, and gender. Although the EURO region has the highest burden, Asia as a continent continues to bear the heaviest brunt of the disease. Although the burden of disease is higher in more developed regions, mortality is considerably higher in less developed regions and this gap widens over the next two decades. The disease predominantly affects the male gender across all regions of the world. Age has a complex relation with the burden of CRC and is affected by the cross-influences relating to socio-economic status.
CONCLUSIONS: The results of our study demonstrate a rising global burden of CRC with some unique variations. Knowledge of this data can increase awareness and help strategic targeting of efforts and resources.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  colorectal cancer; epidemiology; global heath; incidence; mortality

Mesh:

Year:  2017        PMID: 28194798     DOI: 10.1002/jso.24578

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  69 in total

1.  Early tumor shrinkage after first-line medical treatment of metastatic colorectal cancer: a meta-analysis.

Authors:  Giuseppe A Colloca; Antonella Venturino; Domenico Guarneri
Journal:  Int J Clin Oncol       Date:  2019-02-04       Impact factor: 3.402

2.  Oncologic long-term outcomes of emergency versus elective resection for colorectal cancer.

Authors:  Joël L Lavanchy; Lukas Vaisnora; Tobias Haltmeier; Inti Zlobec; Lukas E Brügger; Daniel Candinas; Beat Schnüriger
Journal:  Int J Colorectal Dis       Date:  2019-11-11       Impact factor: 2.571

3.  Contribution of Murine Double Minute 2 Genotypes to Colorectal Cancer Risk in Taiwan.

Authors:  Te-Cheng Yueh; Yi-Wen Hung; Tzu-Ching Shih; Cheng-Nan Wu; Shou-Cheng Wang; Yi-Liang Lai; Shih-Wei Hsu; Ming-Hsien Wu; Chun-Kai Fu; Yun-Chi Wang; Tao-Wei Ke; Wen-Shin Chang; Chia-Wen Tsai; DA-Tian Bau
Journal:  Cancer Genomics Proteomics       Date:  2018 Sep-Oct       Impact factor: 4.069

4.  Low-dose paclitaxel downregulates MYC proto-oncogene bHLH transcription factor expression in colorectal carcinoma cells.

Authors:  Wenjing Li; Wanyun Zhu; Chaoxiang Lv; Hao Qu; Kaixiang Xu; Honghui Li; Haifeng Li; Yiming Du; Guangming Liu; Yunyue Wang; Hong-Jiang Wei; Hong-Ye Zhao
Journal:  Oncol Lett       Date:  2017-12-05       Impact factor: 2.967

5.  Suppression of LINC00460 mediated the sensitization of HCT116 cells to ionizing radiation by inhibiting epithelial-mesenchymal transition.

Authors:  Jiani Zhang; Lixin Ding; Gaofeng Sun; Huacheng Ning; Ruixue Huang
Journal:  Toxicol Res (Camb)       Date:  2020-04-24       Impact factor: 3.524

6.  The Contribution of MMP-7 Genotypes to Colorectal Cancer Susceptibility in Taiwan.

Authors:  Te-Cheng Yueh; Cheng-Nan Wu; Yi-Wen Hung; Wen-Shin Chang; Chun-Kai Fu; Jen-Sheng Pei; Ming-Hsien Wu; Yi-Liang Lai; Yi-Min Lee; Shiou-Ting Yen; Hsin-Ting Li; Chia-Wen Tsai; DA-Tian Bau
Journal:  Cancer Genomics Proteomics       Date:  2018 May-Jun       Impact factor: 4.069

7.  Contribution of Matrix Metalloproteinase-1 Genotypes to Colorectal Cancer in Taiwan.

Authors:  Ming-Hsien Wu; Te-Cheng Yueh; Wen-Shin Chang; Chia-Wen Tsai; Chun-Kai Fu; Mei-Due Yang; Chien-Chih Yu; DA-Tian Bau
Journal:  Cancer Genomics Proteomics       Date:  2021-04-23       Impact factor: 4.069

8.  Quality of Life in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy-The Randomized NORDIC9-Study.

Authors:  Gabor Liposits; Henrik Rode Eshøj; Sören Möller; Stine Brændegaard Winther; Halla Skuladottir; Jesper Ryg; Eva Hofsli; Carl-Henrik Shah; Laurids Østergaard Poulsen; Åke Berglund; Camilla Qvortrup; Pia Österlund; Bengt Glimelius; Halfdan Sorbye; Per Pfeiffer
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

9.  Clinical Assay for the Early Detection of Colorectal Cancer Using Mass Spectrometric Wheat Germ Agglutinin Multiple Reaction Monitoring.

Authors:  I-Jung Tsai; Emily Chia-Yu Su; I-Lin Tsai; Ching-Yu Lin
Journal:  Cancers (Basel)       Date:  2021-05-02       Impact factor: 6.639

Review 10.  Systems-level biomarkers identification and drug repositioning in colorectal cancer.

Authors:  Hande Beklen; Esra Yildirim; Medi Kori; Beste Turanli; Kazim Yalcin Arga
Journal:  World J Gastrointest Oncol       Date:  2021-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.